参考图片
Expression of CD11b on bone-marrow myeloid cells. BALB/c bone-marrow leukocytes were stained with either Biotin Rat Anti-Mouse CD11b (Cat. No. 557395/553309, right panel) or Biotin Rat IgG2b, ĸ Isotype Control (Cat. No. 553987, left panel), followed by Streptavidin-FITC (Cat. No. 554060, both panels). Please note that the population of cells having the lowest SSC (erythroid and lymphoid cells) show little expression of CD11b, while cells with moderate-to-high SSC (myeloid cells) are almost uniformly CD11b positive (right panel). Flow cytometry was performed on a BD FACScan™ flow cytometry system.
Flow cytometric analysis of expression of CD11b on bone-marrow myeloid cells. BALB/c bone-marrow leukocytes were stained with either Biotin Rat IgG2b, κ Isotype Control (Cat. No. 553987, left panel) or Biotin Rat Anti-CD11b (Cat. No. 553309/557395, right panel), followed by FITC Streptavidin (Cat. No. 554060). Please note that the population of cells having the lowest SSC (erythroid and lymphoid cells) show little expression of CD11b, while cells with moderate-to-high SSC (myeloid cells) are almost uniformly CD11b positive (right panel). The fluorescence contour plots were derived from gated events based on the light-scattering characteristics of viable leukocytes. Flow cytometry was performed on a BD FACScan™.
本文来自投稿,不代表本人立场,如若转载,请注明出处:http://www.iamyjet.com/kangti/9277.html